Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Report Type

Organization

Disposition

Year

Month

Found 72722 record(s)

Req # A-2020-000063

Adverse Reaction Report (AER). Report numbers: E2B_02928614, E2B_02934756, E2B_02951574.

Organization: Health Canada

51 page(s)
May 2020

Req # A-2020-000084

Adverse Reaction Report (AER). Report number: 000705709.

Organization: Health Canada

7 page(s)
May 2020

Req # A-2020-000117

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-123505-887, Priorities to Address Aging Information Technology.

Organization: Health Canada

7 page(s)
May 2020

Req # A-2020-000120

Adverse Reaction Report (AER). Report numbers: 000737101, 000737106.

Organization: Health Canada

32 page(s)
May 2020

Req # A-2020-000129

Adverse Reaction Report (AER). Report numbers: E2B_02885721, E2B_02891230, E2B_02894317, E2B_02898124, E2B_02898148.

Organization: Health Canada

67 page(s)
May 2020

Req # A-2020-000205

Adverse Reaction Report (AER) for Cabazitaxel for Injection. Report number: 02487497. ADR for Daptomycin for Injection (350 mg/vial). Report number: 02460009. ADR for Janumet. Report numbers: 02333856, 02333864, 02333872.

Organization: Health Canada

0 page(s)
May 2020

Req # A-2019-02632

Type, frequency and content (topics covered) of training programs that Members of the Immigration Division of the Immigration and Refugee Board receive with respect to mental health issues in fiscal years 2017-2018, 2018-2019, and 2019-2020.

Organization: Immigration and Refugee Board of Canada

51 page(s)
May 2020

Req # A-2019-02633

Any policy briefs, internal directives, guidelines, standard operating procedures, protocols, practice manuals, and instructional documentation relating to immigration detainees with mental health issues and vulnerable immigration detainees issued…

Organization: Immigration and Refugee Board of Canada

7 page(s)
May 2020

Req # A-2019-02634

Quality assurance program reports regarding the Immigration Division of the Immigration and Refugee Board, in fiscal years 2017-2018, 2018-2019, and 2019-2020 for each region across Canada.

Organization: Immigration and Refugee Board of Canada

32 page(s)
May 2020

Req # A-2019-95137

Please provide a list of how many spousal sponsorship applications are processed at each visa post globally. Do not include SCLPC, but do include Canada's processing centre (which does process out of Canada sponsorships). Also provide approval…

Organization: Immigration, Refugees and Citizenship Canada

5 page(s)
May 2020
Date modified: